Identification and Management of ILD in Systemic Sclerosis - Article

From Lancet Rheumatology, this article reviews evidence-based consensus statements on guidance for the identification and medical management of systemic sclerosis-associated ILD.

What you’ll learn:

• The process used in developing evidence-based consensus statements on SSc-ILD management in relation to six domains: risk factors, screening, diagnosis and severity assessment, treatment initiation and options, disease progression, and treatment escalation
• The results of the expert panel regarding the six domains
• The algorithm developed for the identification and management of SSc-associated ILD